Microdial secondary metabolites play important roles in medicine; prospects for discovery of new drugs

Perspectives in Biology and Medicine

Volumn 40, Issue 3, 1997, Pages 364-394

  Bentley, Ronald ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRICULTURAL CHEMICAL; ANTIINFECTIVE AGENT; DRUG; MARINE TOXIN; MYCOTOXIN;

ANIMAL; BACTERIUM; CHEMISTRY; CLASSIFICATION; ETHNOBOTANY; FUNGUS; GENETIC ENGINEERING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; REVIEW;

AGROCHEMICALS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; ETHNOBOTANY; FUNGI; GENETIC ENGINEERING; HUMANS; MARINE TOXINS; MYCOTOXINS; PHARMACEUTICAL PREPARATIONS;

EID: 0031088644     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (96)

1. BUDAVARI, S., ed. The Merck Index, 12th. ed. Whitehouse Station, NJ: Merck and Co. Inc., 1996.
2. BENTLEY, R. Secondary metabolites play primary roles in human affairs. Persp. Biol. Med. 40:197-221, 1997.
3. BÄUMLER, E. Paul Ehrlich: Scientist for Life. New York: Holmes and Meier, 1984. 5-8.
4. SWAN, H. T. Medicine in Sheffield: Incorporating a developed section on the history of penicillin. Quart.}. Med. New Series 81(296):1041-1049, 1991.
5. WAINWRIGHT, M., and SWAN, H. T. G. G. Paine and the earliest surviving clinical records of penicillin therapy. Med. Hist. 30:42-56, 1986.
6. MACFARLANE, G. Alexander Fleming: The Man and the Myth. Cambridge: Harvard Univ. Press,'1984. 136.
7. FRASER-MOODIE, W. Struggle against infection. Proc. Roy. Soc. Med. 64:8794, 1971.
8. BENTLEY, R. From antibiosis to antibiotics: A brief account of early work. Biochemist 12(5):14-17, 1990.
9. PAPACOSTAS, G., and GATE, L. Les associations microbiennes: Leurs applications thérapeutiques. Paris: Gaston Doin and Co., 1928.
10. FLOREY, H. W.CHAIN, E.HEATLEY, N. G.et al. Antibiotics. 2 vols, and II. London: Oxford Univ. Press, 1949.
11. FROST, \V. D. The antagonism exhibited by certain saprophytic bacteria against the Bacillus typhosus Gaffky./ Inf. Dis. 1:599-640, 1904.
12. WILSON, B.J. Miscellaneous Aspergillus toxins. In Microbial Toxins: A Comprehensive Treatise, v. VI, edited by A. CIEGLER, S. KARDIS, and S.J. AJL. New York: Academic Press, 1971. 235-250.
13. BENTLEY, R., and THOMAS, R. Harold Raistrick, F.R.S., 1890-1971: An appreciation. Biochemist 12(6):3-7, 1990.
14. FLEMING, A. Chemotherapy: Yesterday, today and tomorrow. In Fifty Years of Antimicrobials: Past Perspectives and Future Trends, edited by P. A. HUNTER, G. K. DARBY, and N.J. RUSSELL. Cambridge: Cambridge Univ. Press, 1995. 1-18. (Republication of Linacre Lecture, 6 May 1946.)
15. HOTCHKISS, R. D. Gramicidin, tyrocidine, and tyrothricin. Adv. Enzymol. 4: 153-199, 1944.
16. CREASE, R. P. Righting the antibiotic record. Science 246:883-884, 1989.
17. MOBERG, C. L., and COHN, Z. A. René Jules Dubos. Sci. American 264:6674, 1991.
18. BICKEL, L. Rise Up To Life: A Biography of Howard Waller Florey Who Gave Penicillin to the World. London: Angus and Robertspn, 1972.
19. FAI.K, L. A. The history of penicillin. JAMA 129:1219, 1944.
20. MACUANESS, G. B. Neuremedies for an ancient infection: Antibiotics and tuberculosis. In Launching the Antibiotic Era, edited by C. L. MOBERG and Z. A. COHN. New York: Rockefeller Univ. Press. 1990. 57-67.
21. WAINWRIGHT, M. Miracle Cure: The Story of Penicillin and the Golden Age of Antibiotics. Oxford: Basil Blackwell, 1990.
22. BRUNEI., J. Qui a découvert la pénicilline? Rev. Canad. de Biol. 3:333-343, 1944.
23. FLEMING, A. On the antibacterial action of cultures of a Pénicillium with special reference to their use for the isolation of B. influenzae. Brit. J. Exp. Path. 10:226-236, 1929.
24. HARE, R. The Birth of Penicillin and the Disarming of Microbes. London: Allan and Unwin, 1970. 81-87.
25. CLUTTERBUCK, P. W.LOVELL, R.and RAISTRICK, H. Studies in the biochemistry of microorganisms. XXVI. The formation from glucose by members of the Penicillium chrysogenum series of a pigment, an alkali-soluble protein and penicillin: The antibacterial substance of Fleming. Biochem. J. 26:1907-1918, 1932.
26. CHRISTENSEN, C. M. The Molds and Man: An Introduction to the Fungi. Minneapolis: Univ. of Minnesota Press, 1951.
27. WAINWRIGHT, M. The history of the therapeutic use of crude penicillin. Med. Hist. 31:41-50, 1987.
28. LASAGNA, L. The diseases drugs cause. Persp. Biol. Med. 7:457-470, 1963-1964.
29. REIMANN, H. A. The misuse of antimicrobics. Med. Clin. North Am. 45:849-856, 1961.
30. CHIN, G. J., and MARX, J., eds. Frontiers in biotechnology: Antibiotic resistance. Special issue of Science 264:359-393) 1994.
31. ZÄHNER, H., and FIEDLER, H.-P. The need for new antibiotics: Possible ways forward. In Fifty Years of Antimicrobials: Past Perspectives and Future Trends, edited by P. A. HUNTER, G. K. DARBY, and N.J. RUSSELL. Cambridge: Cambridge Univ. Press, 1995. 67-84.
32. KERR, K. G., and LACEY, R. W. Why do we still have epidemics? In Fifty Years of Antimicrobials: Past Perspectives and Future Trends, edited by P. A. HUNTER, G. K. DARBY, and N.J. RUSSELL. Cambridge: Cambridge Univ. Press, 1995. 179-203.
33. BURG, R. W. Fermentation products in animal health. Am. Soc. Microbiol. News 48:460-463, 1982.
34. OMURA, S. Preface. In The Search for Bioaclive Compounds from Microorganisms, edited by S. OMURA. New York: Springer Verlag, 1992. vii-viii.
35. MATOSSIAX, M. K. Poisons of the Past: Molds, Epidemics, and History. New Haven: Yale Univ. Press, 1989.
36. BOVÉ, F. J. The Story of Ergot. Basel: S. Karger, 1970.
37. VINING, L. C., and TARER, W. A. Ergot alkaloids. In Secondary Products of Metabolism; Economic Microbiology, v. 3, edited by A. H. ROSE. London: Academic Press, 1979. 389-420.
38. FLOSS, H. G., and ANDERSOX, J. A. Biosynthesis of ergot toxins. In The Biosynthesis of Mycotoxins; A Study in Secondary Metabolism, edited by P. S. STEW. New York: Academic Press, 1980. 17-67.
39. STOLI., A. Verfahren zur Isolierung des reinen kristallisierten Hauptalkaloids aus Secale cormitum. Swiss Patent 86321. Application date 10 March 1919; granted 16 August 1920.
40. DETROY, R. W.LILLEHOJ, E. B.and CIEGI.ER, A. Aflatoxins and related compounds. In Microbial Toxins, v. 6, edited by A. CIEGI.ER, S. KADIS, and S. J. AJL. New York: Academic Press, 1971. 4-178.
41. MIROCHA, C. J.PATURE, S. V.and CHRISTENSEN, C. J. Mycotoxins. In Secondary Products of Metabolism: Economie Microbiology, v. 3, edited by A. H. ROSE. London: Academic Press, 1979. 467-522.
42. BLACKWEI.L, W. H. Poisonous and Medicinal Plants. Englcwood Cliffs: Prentice Hall, 1990.
43. JOFFE, A. Z. Alimentary toxic aleukia. In Microbial Toxins, v. 7, edited by S. KADIS, A. CIEGI.ER, and S. J. AJL. NY: Academic Press, 1971. 139-206.
44. BAMBURG, J. R., and STRONG, F. M. 12,13-epoxytricothecenes. In Microbial Toxins, v. 7, edited by S. KADIS, A. CIEGI.ER, and S. J. AJL. New York: Academic Pres, 1971. 207-292.
45. JARVIS, B. The occurrence of mycotoxins in UK foods. Food Technol. in Australia 34(11) :508-514, 1982.
46. TAYI.OR, A. The toxicology of sporidesmins and other epipolythia-dioxopiperazines. In Microbial Toxins, v. 7, edited by S. KADIS, A. CIEGI.ER, and S. J. AJL. New York: Academic Press, 1971. 337-376.
47. PALEG, L. G. Physiological effects of gibberellins. Ann. Rev. Plant Physiol. 16:291-322, 1965.
48. RAPPAPORT, L. Applications of gibberellins in agriculture. In Plant Growth Substances 1979, edited by F. SKOOG. Berlin: Springer Verlag, 1980. 377-391.
49. LOONEY, N. E. Growth regulator use in commercial apple production. In Plant Growth Substances 1979, edited by F. SKOOG. Berlin: Springer Verlag, 1980. 409-418.
50. BURGE, M. N. Microbes and microbial phytotoxins, as herbicides. In Drugs from Natural Products, edited by A. L. HARVEY. Chichcster: Ellis Honvood, 1993. 82-98.
51. OKUDA, S., and TANAKA, Y. In The Search for Bioactive Compounds from Microorganisms, edited by S. OMURA. New York: Springer Verlag, 1992. 213-223.
52. RUSSELL, P. E.MILLING, R. J.and WRIGHT, K. Control of fungi pathogenic to plants. In Fifty Years of Antimicrobials: Past Perspectives and Future Trends, edited by P. A. HUNTER, G. K. DARBY, and N:'J. RUSSELL. Cambridge: Cambridge Univ. Press, 1995. 85-110.
53. MIROCHA, C. J.CHRISTENSEN, C. M.and NELSON, G. H. F-2 (Zearalenone) estrogenic mycotoxin from Fusarium. In Secondary Products of Metabolism: Economic Microbiology, v. 3, edited by A. H. ROSE. London: Academic Press, 1979. 107-138.
54. YAMADA, H. Immunomodulators. In The Search for Bioactive Compounds from Microorganisms, edited by S. OMURA. New York: Springer Verlag, 1992. 171-197.
55. NICOLAU, K. C.CHAKRABORTY, T. K.PISCOPIO, A. D.et al. Total synthesis of rapamycin.y. Amer. Chein. Soc. 115:4419-4420, 1993.
56. KUNZ, J., and HALL, M. N. Cyclosporin A, FK506 and rapamycin: More than just immunosuppresants. Trends Biochem. Sci. 18(9):334-338, 1993.
57. TANAKA, H.KAWAKITA, K.IMAMURA, N.et al. General screening of enzyme inhibitors. In The Search for Bioactive Compounds from Microorganisms, edited by S. OMURA. New York: Springer Verlag, 1992. 117-160.
58. KOMIYAMA, K., and FUNAYAMA, S. Antitumor agents. In The Search for Bioactive Compounds from Microorganisms, edited by S. OMURA, New York: Springer Verlag, 1992. 79-103.
59. TAKESHIMA, H. Antiviral agents. In The Search for Dioactive Compounds from Microorganisms, edited by S. OMURA. New York: Springer Verlag, 1992, 4562.
60. CHADWICK, D. J., and MARCH, J., eds. Ethnobotany and the Search for New Drugs. Ciba Foundation Symposium 185, Chichester: John Wiley, 1994.
61. KING, S. R., and TEMPESTA, M. S. From shaman to human clinical trials: The role of industry in ethnobotany, conservation and community reciprocity. In Ethnobotany and the Search for New Drugs. Ciba Foundation Symposium 185 Chicester: John Wiley, 1994. 197-213.
62. THOMAS, R. M. Eligio Panti, 103, Maya healer with modern ties. New York Times, 10 February 1996.
63. COX, P. A., and BALICK, M. J. The ethnobotanical approach to drug discovery. Scientific Am. 270(6):82-87, 1994.
64. COX, P. A. The ethnobotanical approach to drug discovery: Strengths and limitations. In Ethnobotany and the Search for New Drugs. Ciba Foundation Symposium 185. Chichester: John Wiley, 1994. 25-41.
65. FARNSWORTH, N. R. Ethnopharmacology and drug development. In Ethnobotany and the Search for Neiu Drugs. Ciba Foundation Symposium 185 Chichester: John Wiley, 1994. 42-59.
66. GUSTAFSON, K. R.CARDELLINA, J. H.McMAiiON, J. B.et al. Anonpromoting phorbol from the Samoan medicinal plant Homolanthus nutans inhibits cell killing by HIV-1.J. Med. Chem. 35:1978-1986, 1992.
67. CRAVEIRO, A. A. Discussion of paper by N. R. Farnsworth, Ethnopharmacology and drug development. In Ethnobotany and the Search for New Drugs. Ciba Foundation Symposium 185. Chichester: John Wiley, 1994, 55.
68. CUNNINGHAM, A. B., and MBENKUM, F. T. Sustainability of harvesting Pn/nt africanusbark in Cameroon: A medicinal plant in international trade. People and Plants \VorkingPaper2. Paris: UNESCO, 1993.
69. GENTRY, A. H. Tropical forest biodiversity and the potential for new medicinal plants. In Human Medicinal Agents from Plants; edited by A. D. KINGHORN, & M. F. BALANDRIN. Washington, DC: American Chemical Society, 1993. 13-24.
70. PRANCE, G. T. Introduction. In Ethnobolany and the Search for New Drugs. Ciba Foundation Symposium 185. Chichester: John Wiley 1994. 1-3.
71. BALICK, M. J. Ethnobotany, drug development and biodiversity conservation: Exploring the linkages. In Elhnobotany and the Search for New Drugs. Ciba Foundation Symposium 185 Chichester: John Wiley, 1994. 4-24.
72. MILSTEIN, M. Yellowstone managers stake a claim on hot-springs microbes. Science 270:266, 1995.
73. WOLFGANG, L. Patents on native technology challenged. Science 269:1506, 1995.
74. BURNS, J. F. Tradition in India vs. a patent in the U.S. Neio York Times, 15 September 1995, C4.
75. BERRY, D. R.SMITH, J. E.and HARVEY, L. Non-antibiotic drugs from fungal and other microbial sources. In Drugs from Natural Products, edited by A. L. HARVEY, Chichester: Ellis Horwood, 1993. 18-34.
76. FAULKNER, D. J. Chemical riches from the oceans. Chem. Brit. 31:680-684, 1995.
77. KöNIG, G. M., and WRIGHT, A. D. Algal secondary metabolites and their pharmaceutical potential. In Human Medicinal Agents from Plants, edited by A. D. KiNGHORNand M. F. BAIANDRIN. Washington, DC: American Chemical Society, 1993. 276-293.
78. FLAM, F. Chemical prospectors scour the seas for promising drugs. Science 266:1324-1325, 1994.
79. RINEHART, K. L. Secondary metabolites from marine organisms. In Secondary Metabolites: Their Function and Evolution. Ciba Foundation Symposium 171, edited by D.J. CHADWICK and J. WHELAN. Chichester:John Wiley, 1992. 236-245.
80. LOVELL, F. M. The structure of a bromine-rich marine antibiotic. J. Am. Chem. Soc. 88:4510-4511, 1966.
81. ROUHI, A. M. Supply isues complicate trek of chemicals from sea to market. Chem. Eng. News 73(47):42-44, 1995.
82. JENSEN, P. R., and FENICAL, W. Strategies for the discovery of secondary metabolites from marine bacteria: Ecological perspectives. Ann. Rev. Microbiol. 48:559-584, 1994.
83. SIMIDU, U.NOGUCHI, T.HWANG, D.-F.et al. Marine bacteria which produce tetrodotoxin. Appl. Environ. Microbiol. 53:1714-1715, 1987.
84. Do, H. K.KOGURE, K.and SIMIDU, U. Identification of deep-sea-sediment bacteria which produce tetrodotoxin. Appl. Environ. Microbiol. 56:1162-1163, 1990.
85. O-HAGAN, O. The Polyketide Metabolites. New York: Ellis Honvood, 1991.
86. SAMSON, S. M.BELAGAJE, R.BLANKENSHIP, D. T.et al. Isolation, sequence determination and expression in Escherichia coli of the isopenicillin N synthetase gene from Cephalosporium ammonium. Nature 318:191-1194, 1985.
87. SKATRUD, P. Genetic engineering of β-lactam biosynthetic pathways in filamentous fungi. Trends Biotech. 10:324-329, 1992.
88. HOPWOOD, D. A., and SHERMAN, D. H. Molecular .genetics of polyketides and comparison to fatty acid biosynthesis. Ann. Rev. Genetics 24:37-66,1990.
89. KATZ, L., and DONADIO, S. Polyketide synthesis: Prospects for hybrid antibiotics. Ann. Rev. Microbiol. 47:875-912, 1993.
90. HUTCHINSON, C. R., and FUJH, I. Polyketide synthase gene manipulation: A structure-function approach in engineering novel antibiotics. Ann. Rev. Microbiol. 49:201-238, 1995.
91. CORTES, J.WIESMANN, K. E. H.ROBERTS, G., A.et al. Repositioning of a domain in a modular polyketide synthase to promote specific chain cleavage. Science 268:1487-1489, 1995.
92. WIESMANN, K. E. H.CORTES, J.BROWN, M. J. B.et al. Polyketide synthesis on a synthase. Chem. & Biol. 2:583-589, 1995.
93. PIEPER, R.Luo, G.CANE, D. E.and KHOSLA, C. Cell-free synthesis of polyketides by recombinant erytliromycin polyketide synthases. Nature 378: 263-266, 1995.
94. STAUNTON, J.COFFREY, P.APRICCIO, J. F.et al. Evidence for a doublehelical structure for modular polyketide synthases. Nature Struct. Biol. 3: 188-192, 1996.
95. BENNETT, J. W., and BENTI.EY, R. What's in a name? Microbial secondary metabolism. Adv. Appl. Microbiol. 34:1-28, 1989.
96. TENNYSON, A. Locksley Hall, M. In the The Poems of Tennyson, 2nd ed., edited by C. RICKS. Harlow, Essex: Longman 1987. 118-130. This poem, probably written in 1837-1838, was published in 1842.